Common type 2 diabetes drugs may raise heart risk, study reveals

Credit: Unsplash+

Type 2 diabetes, a condition where the body struggles to effectively use insulin to control blood sugar levels, is becoming a major health concern.

Metformin is typically the first-line treatment, but if it fails to sufficiently control blood sugar, additional medications may be required.

However, a recent study from Northwestern University suggests that two commonly prescribed drugs for type 2 diabetes could elevate heart risk.

Study’s Findings on Second-Line Diabetes Drugs

In the study, researchers analyzed six second-line drugs typically prescribed for type 2 diabetes.

They discovered that two drugs, sulfonylureas and basal insulin, were associated with an increased risk of heart problems compared to a newer class of diabetes drugs known as DPP-4 inhibitors.

The heart risk was 36% higher with sulfonylureas and doubled with basal insulin.

Recommendations for Safer Medications

The study’s findings indicate that doctors may want to prescribe newer medications, like GLP-1 agonists, SGLT-2 inhibitors, or DPP-4 inhibitors, over sulfonylureas or basal insulin.

While these drugs might be more expensive, they have demonstrated better safety for the heart and could help prevent costly hospitalizations due to serious heart problems.

Significance and Limitations of the Study

This research is critical because it raises safety concerns about commonly prescribed type 2 diabetes drugs.

However, the study has its limitations: it relied on real-world evidence from a large patient population and was not a controlled experiment.

The research didn’t directly compare the efficacy of these drugs in controlling blood sugar levels and didn’t investigate whether some patients might still benefit from these drugs.

More research is needed to fully understand these medications’ effectiveness and potential risks.

Advice for People with Type 2 Diabetes

People with type 2 diabetes should be aware of their medication and its potential impact on their heart health.

The study suggests that sulfonylureas and basal insulin might increase heart problems’ risk, making it vital for patients to have transparent discussions with their doctors about potential risks and alternative, safer medications.

Informed Treatment Choices and Heart Health Maintenance

When choosing a treatment for type 2 diabetes, the potential risks and benefits of different medications should be taken into account.

Newer medications may be safer for the heart, despite their higher initial cost.

Alongside medication, lifestyle modifications such as regular exercise, balanced diet, weight management, quitting smoking, adequate sleep, and stress management can contribute significantly to heart health.

Prioritizing heart health is essential for a long and healthy life with type 2 diabetes.

If you care about blood sugar, please read studies about why blood sugar is high in the morning, and how to cook sweet potatoes without increasing blood sugar.

For more information about brain health, please see recent studies about 9 unhealthy habits that damage your brain, and results showing this stuff in cannabis may protect aging brain, treat Alzheimer’s.

Follow us on Twitter for more articles about this topic.

Copyright © 2023 Knowridge Science Report. All rights reserved.